Literature DB >> 33633566

Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.

Federica Mannino1, Alessandra Bitto1, Natasha Irrera1.   

Abstract

The new coronavirus outbreak was first identified in Wuhan, China, in December 2019, and has turned out to be a global health emergency, affecting millions of people worldwide. Coronavirus disease 19 (COVID-19), caused by the SARS-CoV-2 virus, can manifest with flu-like symptoms and can be complicated by severe pneumonia with acute respiratory distress syndrome (ARDS); however a large percentage of infected individuals do not have symptoms but contribute to the spread of the disease. Severe acute respiratory syndrome coronavirus-2 infection has become a global public health emergency since no available treatment seems effective and it is hard to manage the several complications caused by an intense release of cytokines. This paper reviews the current options on drugs used to reduce the deadly effects of the cytokine storm.
Copyright © 2020 Mannino, Bitto and Irrera.

Entities:  

Keywords:  Therapeutics; coronavirus disease; cytokine storm; inflammation; severe acute respiratory syndrome coronavirus

Year:  2020        PMID: 33633566      PMCID: PMC7902081          DOI: 10.3389/fphar.2020.592169

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  69 in total

1.  Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.

Authors:  Ilona Glowacka; Stephanie Bertram; Petra Herzog; Susanne Pfefferle; Imke Steffen; Marcus O Muench; Graham Simmons; Heike Hofmann; Thomas Kuri; Friedemann Weber; Jutta Eichler; Christian Drosten; Stefan Pöhlmann
Journal:  J Virol       Date:  2009-10-28       Impact factor: 5.103

2.  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.

Authors:  Martin J Vincent; Eric Bergeron; Suzanne Benjannet; Bobbie R Erickson; Pierre E Rollin; Thomas G Ksiazek; Nabil G Seidah; Stuart T Nichol
Journal:  Virol J       Date:  2005-08-22       Impact factor: 4.099

3.  SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6.

Authors:  Shih-Wen Li; Ching-Ying Wang; Yu-Jen Jou; Su-Hua Huang; Li-Hsin Hsiao; Lei Wan; Ying-Ju Lin; Szu-Hao Kung; Cheng-Wen Lin
Journal:  Int J Mol Sci       Date:  2016-05-05       Impact factor: 5.923

4.  Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Garima Sharma; Manojit Bhattacharya; Rudra P Saha; Sang-Soo Lee
Journal:  Arch Med Res       Date:  2020-05-30       Impact factor: 2.235

Review 5.  COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2).

Authors:  Yang Song; Min Zhang; Ling Yin; Kunkun Wang; Yiyi Zhou; Mi Zhou; Yun Lu
Journal:  Int J Antimicrob Agents       Date:  2020-07-04       Impact factor: 5.283

6.  Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.

Authors:  Ivan Fan-Ngai Hung; Kwok-Cheung Lung; Eugene Yuk-Keung Tso; Raymond Liu; Tom Wai-Hin Chung; Man-Yee Chu; Yuk-Yung Ng; Jenny Lo; Jacky Chan; Anthony Raymond Tam; Hoi-Ping Shum; Veronica Chan; Alan Ka-Lun Wu; Kit-Man Sin; Wai-Shing Leung; Wai-Lam Law; David Christopher Lung; Simon Sin; Pauline Yeung; Cyril Chik-Yan Yip; Ricky Ruiqi Zhang; Agnes Yim-Fong Fung; Erica Yuen-Wing Yan; Kit-Hang Leung; Jonathan Daniel Ip; Allen Wing-Ho Chu; Wan-Mui Chan; Anthony Chin-Ki Ng; Rodney Lee; Kitty Fung; Alwin Yeung; Tak-Chiu Wu; Johnny Wai-Man Chan; Wing-Wah Yan; Wai-Ming Chan; Jasper Fuk-Woo Chan; Albert Kwok-Wai Lie; Owen Tak-Yin Tsang; Vincent Chi-Chung Cheng; Tak-Lun Que; Chak-Sing Lau; Kwok-Hung Chan; Kelvin Kai-Wang To; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-05-10       Impact factor: 79.321

7.  Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.

Authors:  Xiaohua Chen; Binghong Zhao; Yueming Qu; Yurou Chen; Jie Xiong; Yong Feng; Dong Men; Qianchuan Huang; Ying Liu; Bo Yang; Jinya Ding; Feng Li
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

8.  Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals.

Authors:  Linqi Zhang; Fengwen Zhang; Wenjie Yu; Tian He; Jian Yu; Christopher E Yi; Lei Ba; Wenhui Li; Michael Farzan; Zhiwei Chen; Kwok-Yung Yuen; David Ho
Journal:  J Med Virol       Date:  2006-01       Impact factor: 2.327

9.  Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study.

Authors:  Jing Chen; Shaowu Lin; Conway Niu; Qi Xiao
Journal:  Expert Rev Respir Med       Date:  2020-09-17       Impact factor: 3.772

10.  A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.

Authors:  Bin Cao; Yeming Wang; Danning Wen; Wen Liu; Jingli Wang; Guohui Fan; Lianguo Ruan; Bin Song; Yanping Cai; Ming Wei; Xingwang Li; Jiaan Xia; Nanshan Chen; Jie Xiang; Ting Yu; Tao Bai; Xuelei Xie; Li Zhang; Caihong Li; Ye Yuan; Hua Chen; Huadong Li; Hanping Huang; Shengjing Tu; Fengyun Gong; Ying Liu; Yuan Wei; Chongya Dong; Fei Zhou; Xiaoying Gu; Jiuyang Xu; Zhibo Liu; Yi Zhang; Hui Li; Lianhan Shang; Ke Wang; Kunxia Li; Xia Zhou; Xuan Dong; Zhaohui Qu; Sixia Lu; Xujuan Hu; Shunan Ruan; Shanshan Luo; Jing Wu; Lu Peng; Fang Cheng; Lihong Pan; Jun Zou; Chunmin Jia; Juan Wang; Xia Liu; Shuzhen Wang; Xudong Wu; Qin Ge; Jing He; Haiyan Zhan; Fang Qiu; Li Guo; Chaolin Huang; Thomas Jaki; Frederick G Hayden; Peter W Horby; Dingyu Zhang; Chen Wang
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

View more
  2 in total

1.  Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19.

Authors:  Anna E Spiering; Teun J de Vries
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

Review 2.  Neurological complications of COVID-19 in children and the associated immunological responses.

Authors:  Rabeea Siddique; Suliman Khan; Manqi Li; Mengzhou Xue; K Al Ghanim; Zahid Ali Kaimkhani; Shahid Mahboob
Journal:  J King Saud Univ Sci       Date:  2022-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.